- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01776931
Determination of Lysine Requirements in Pregnancy
Determination of Lysine Requirements in Healthy Pregnant Women Using the Indicator Amino Acid Oxidation Technique
Amino acids are building blocks of protein in our body. It is important that pregnant women eat adequate amount of protein/amino acids to ensure healthy growth and development of the fetus.Lysine is an amino acid that is present in high amounts only in animal foods (meat) and not much in plant foods such as wheat. Currently , it is not known how much lysine is needed to eat during pregnancy.
Current Dietary Reference Intake recommendations for amino acid requirements are based on non-pregnant adults, and minimally based on pregnancy-specific data.To the investigators knowledge, there is no scientific information regarding the amount of lysine needed at different stages of pregnancy.
The investigators hypothesize that current recommendations for lysine intake in pregnant women are underestimated. The investigators also hypothesize that the lysine requirements will be greater during the later stages of pregnancy, compared to early stages.
The purpose of this study is to determine lysine requirements in healthy pregnant women 19-40y,(1st and 3rd trimester) using a modern, safe and quick technique called the indicator amino acid oxidation technique and to compare lysine requirements during early (15-18 weeks last menstrual period) late (33-36 weeks last menstrual period) stages of pregnancy.
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V5Z 4H4
- Child & Family Research Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Singleton pregnancy
- Maternal age 19-40y
- Early stage of pregnancy(15-18 weeks) and late stage of pregnancy(33-36 weeks)
- In good health (free of chronic/acute illness, full range of physical mobility)
- Healthy pre-pregnancy body mass index
Exclusion Criteria:
- Subjects outside the age range of 19-40y
- Women pregnant with more than one child
- Body mass Index less than 18.5kg/m2 or greater than 25 kg/m2
- less than 18 months between current pregnancy and last pregnancy
- History of spontaneous abortion,pre-term birth, preeclampsia/eclampsia, gestational diabetes, pregnancy-related anemia, pregnancy related jaundice
- Existing metabolic disease
- Substance dependance (i.e. alcohol, cigarette, illicit drugs)
- Allergic to eggs and egg protein
- Severe nausea and vomiting during pregnancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Lysine intake
Dietary supplement:lysine intake
|
Oral consumption of Eight hourly experimental meals- Includes 4 tracer-free experimental meals containing a mixture of free amino acids, calories from a flavored liquid and protein free cookies and 4- labeled amino acid experimental meals.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
13 carbon dioxide production
Time Frame: 8 hours (1 study day)
|
Urine and breath samples will be collected during the study to measure the rate of oxidation of tracer in expired breath and flux by enrichment in urine.
|
8 hours (1 study day)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Rajavel Elango, PhD, Child & Family Research Institute/University of British Columbia
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- H11-02435
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy
-
Far Eastern Memorial HospitalCompletedCornual PregnancyTaiwan
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Meir Medical CenterRecruiting
-
Bagcilar Training and Research HospitalRecruitingEctopic PregnancyTurkey (Türkiye)
-
MELISA Institute Genomics & Proteomics Research...RecruitingHealthy | Pregnancy | Early Pregnancy | Early Pregnancy Loss | ChildbirthChile
-
Ufuk UniversityNot yet recruitingPregnancy Complications | Pregnancy Loss | Pregnancy Preterm
-
Hadassah Medical OrganizationCompleted
-
Turku University HospitalUniversity of TurkuCompleted
-
Centre Hospitalier Universitaire de Saint EtienneCompletedProlonged PregnancyFrance
-
Zagazig UniversityCompleted
Clinical Trials on Lysine intake
-
The Hospital for Sick ChildrenCompleted
-
University of ArkansasCompletedProtein MetabolismUnited States
-
University of ArkansasCompletedProtein MetabolismUnited States
-
University of Veterinary and Animal Sciences, Lahore...CompletedHyperglycemia | Glucose Metabolism Disorders | Glycemic Index | Metabolic DiseasePakistan
-
Emory UniversityNational Institute of Mental Health (NIMH)Recruiting
-
Medical University of BialystokMinistry of Science and Higher Education, PolandCompletedDiabetes Mellitus, Type 2 | Metabolic Syndrome | Diet Modification | Overweight and Obesity | Genetic PredispositionPoland
-
Maastricht University Medical CenterNot yet recruitingNo Condition, Healthy IndividualsNetherlands
-
The Hospital for Sick ChildrenCompleted
-
University of LeedsCompletedHip Fracture (First Incidence of)United Kingdom
-
University of WashingtonNational Cancer Institute (NCI)CompletedMucositis | Recurrent Salivary Gland Cancer | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent Squamous Cell Carcinoma of the Oropharynx | Recurrent Verrucous Carcinoma... and other conditionsUnited States